马斯克脑机接口公司重大突破，1.5秒快速植入电极，万人等待上脑

Core Viewpoint - Neuralink is making significant advancements in brain-computer interface (BCI) technology, aiming to enhance the quality of life for patients with paralysis and other neurological conditions through innovative surgical techniques and devices [1][4]. Group 1: Technological Advancements - The speed of the new generation surgical robot for implanting single electrode wires has improved from 17 seconds to 1.5 seconds, making it adaptable for 99% of the global population [2]. - Over a dozen subjects are currently using the device for 8 hours daily, with more than 10,000 patients waiting for treatment [2]. - The new surgical robot has increased the speed of inserting single electrode wires by several times compared to existing robots [2]. - Neuralink is developing a new type of implant needle capable of penetrating over 50mm into the brain's surface to access a richer array of neurons [2][12]. - The manufacturing cost of the needle holder has been reduced by 95% [2]. Group 2: BCI Technology and Applications - BCI technology translates neural signals into output commands, enabling control of external devices, with initial goals focused on improving the lives of millions of paralyzed patients [4]. - The first product, "Telepathy," allows individuals with spinal cord injuries or ALS to control computers and mobile devices through thought [15]. - A subject was able to play the game "Civilization VI" for 9 hours after receiving the BCI implant, showcasing the potential for everyday applications [15]. Group 3: Future Prospects - Neuralink has made continuous technological progress since its establishment in 2016, with the first human brain chip implantation scheduled for 2024 [12]. - The company aims to make surgeries as routine as LASIK eye surgery, potentially completing procedures within an hour and even while patients are awake [6]. - The long-term vision includes achieving a high-density device with thousands of channels to record more neurons and gather more information [12].